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THE FUTURE OF LUNG DISEASES: 
COPD MODEL FOR SLOVAKIA 
M. Rusnak*, A. Yashin** and P. Kristufik*** 
INTRODUCTION 
The initial explorations of bronchial t r e e  pathology can be  t raced back t o  the  
ear ly p a r t  of the nineteenth century. Laennec w a s  the  f i r s t  t o  demonstrate the  
so-called "catarrh pulmonaire" and i t s  significance t o  t he  disease (Ba jan 1983). but 
the  attention of physicians centered upon tuberculosis and pneumonia up until the 
1950s. The death of more than 4000-mainly older-people during a catastrophic 
four-day smog in London (1952) and the realization tha t  chronic bronchitis and i ts  
complications were the  fatal causes has proved the importance of studying this 
group of diseases (Protivinski 1968). 
Intensive research  has demonstrated the  necessity f o r  a more precise defini- 
tion of the  group of illnesses described under the general term chronic nonspecif- 
ic  lung diseases. Common effor ts  of specialists from all over  the world have cul- 
minated in accepted definitions of chronic bronchitis, pulmonary emphysema and 
bronchial asthma by the World Health Organisation (WHO 1980). Recently, a com- 
mon term has been used by mostly American authors f o r  all  of these diagnostic un- 
its: chronic obstructive pulmonary disease (COPD). 
Numerous studies have shown an undesirable spread  of COPD in the  developed 
countries. The high and still growing prevalence of these diseases creates a bur- 
den on health-care systems, which leads to  an  associated growth in health c a r e  ex- 
penditures and in the  number of sick-leave cases and disabled people. 
It  is generally understood tha t  the  causes of COPD are largely from within the  
society itself: life style (smoking), environmental (air)  pollution, working condi- 
tions, and social and economic circumstances are believed t o  be  responsible f o r  
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the onsets of these chronic diseases. The growth in COPD prevalence is influenced 
by recent  demographic trends, especially population aging. 
The large proportion of people with these sicknesses makes a complete regis- 
tration of a l l  tine cases a practical impossibility. But COPD prevalence must be es- 
timated in some way because of the  necessity t o  forecaste  and plan appropriate  
health care resources.  We have developed an  appropriate  tool f o r  the analysis of 
possible trends and descr ibe COPD model in this paper .  The authors  hope tha t  i t  
will be  of some help in answering specific questions about COPD development. The 
model uses data  from the  Slovak Socialist Republic and allows the  user  t o  test 
several  scenarios,  as described in Chapter 7. 
1. COPD EPIDEMIOLOGY IN SOME COUNTRIES 
Much new information on COPD and i t s  effect on the  health of the  population 
has been revealed in numerous epidemiological studies. For example, i t  w a s  shown 
tha t  17% of al l  British general practit ioners in the i r  fifties have symptoms of COPD, 
as do 37.8% of older physicians (Pride 1977); Hutli from Finland found COPD in 27% 
of the  population surveyed (Press  and Rufener-Press 1974) and the  prevalence of 
COPD in Sweden is estimated t o  be less than 2% (Kirilog and Irnell  1974). Morbidity 
of chronic bronchitis in the US differs according t o  t he  areas surveyed and the  
chosen population groups: 23.5% in telephone companies' employees, 21.3% in the 
inhabitants of smaller industrial towns, 11% in r u r a l  areas (Mueller et al. 1971). 
Other American surveys have revealed tha t  27% of t he  male and 13% of t he  female 
populations have symptoms and/or spirometric abnormalities indicating COPD (Hig- 
gins and Keller 1970). Swiss data  f o r  the male population in Geneva found the  oc- 
cur rence  of COPD t o  be between 2.7% in men 20-29 years  old and up t o  7.7% in men 
over  60 years  old (Press  and Rufener-Press 1974). 
There have been several  epidemiological studies of COPD prevalence in 
Czechoslovakia. In a group of 8298 men (52-67 years  old) from Prague, 32% were 
found t o  have COPD. In r u r a l  a reas ,  cases were found in 24.8% of men 40-64 years  
old and in 7% of the  women (Boudik et al. 1969b). From 1971 t o  1975, a group of 
20000 men 15 years  and older (in t he  Czechoslovak area along the  Danube r iver )  
were checked f o r  symptoms of COPD. Of this group, 18.4% were diagnosed as hav- 
ing chronic bronchitis (Virsik et al. 1976). 
The data  on COPD mortality does not adequately descr ibe t he  importance of 
this disease in t he  population. Several fac t s  can explain this situation: 
Frequent coincidence of COPD with o ther ,  especially cardiovascular,  diseases; 
Many physicians tend t o  r e f e r  t o  complications of COPD r a t h e r  than the  main 
disorder  as a primary cause of death (Fletcher et al .  1964); 
Sometimes t h e  terminal bronchopneumonia o r  o the r  concomittant disease is  
classified as a cause of death instead of COPD (Herles 1964). 
According t o  Higgins (1973) 30-40 thousand deaths p e r  yea r  in t he  US are 
caused by chronic disorders  of t he  pulmonary system. In Table 1 w e  summarize the  
number of people who died from COPD in different countries of t h e  world in 1980 
(WHO 1982). 
Table 1. Number of deaths  from COPD in different countries by sex and age (WHO 
1982). 
Number of deaths 
Country 
Austria 
Bulgaria 
FRG 
Hungary 
Netherlands 
Poland 
England and Wales 
Japan 
Absolute Percent  of all 
Total Male Female Total Male Female 
1710 1069 641 1.8 2.4 1.3 
3647 2380 1267 3.7 4.4 2.8 
22025 15079 6946 3.1 4.3 1.9 
7043 443 2612 4.8 5.8 3.8 
2750 2147 603 2.4 3.4 1.1 
10096 7229 2867 2.8 3.8 1.8 
20735 14802 5933 3.6 5.0 2.0 
12712 8022 4690 1.7 0.2 1.4 
Very important are t he  data  on other ,  indirect indices of COPD morbidity, 
since, f o r  example, 10% of all sick-leave in t he  US is  caused by COPD. 90 million US 
dollars are paid f o r  sick leave t o  invalids with chronic bronchitis (Higgins 1973) 
and the re  were 4.3 cases of COPD related sick-leave p e r  100 employees in France 
in 1978 (Pedrizet et al .  1978). Recent estimates of COPD prevalence in t h e  US give 
10  million people and, collectively, chronic lung diseases account f o r  more than 
half a million hospital admissions annually. ' lhe limitation of activity occurs  l a t e r  
in life s o  t ha t  Medicare pays a large percentage of t h e  health care costs (DHHS 
1984). The increase in t he  number of sick-leave cases,  hospitalizations, and hospi- 
t a l  days f o r  COPD in Czechoslovakia from the  yea r  1971 is  illustrated in Figure 1. 
- 4 -  
The continuous increase of all t he  indices is visible (CSSR zdravotnictvi 1983). 
2. WHYA COPD MODEL? 
Understanding the  fac t s  and recognizing t h e  importance of t he  effects of 
chronic,  noninfectious diseases on the  health s ta tus  of population led us t o  design 
a COPD mathematical model. The aim of the  model i s  to facilitate the  estimation of 
COPD prevalence and i ts  development as t he  basis f o r  creating a rational forecast  
of health care development. I t  could s e rve  as a test f o r  various hypotheses about 
the  development of t h e  illness in t h e  affected population. The scope of t h e  model i s  
broader  than t h e  health care system itself, since i t  includes aspects  of social c a r e ,  
environment, and economics. This integrative approach introduces quantitative 
expressions f o r  new ideas tha t  frequently appea r  in t h e  l i t e ra ture  on health care 
and clinical medicine. The model is based on an understanding of t he  causes and 
r isk fac tors  responsible f o r  t he  onset and development of COPD. 
3. CAUSES AND DEYELOPMENT OF COPD 
Chronic obstructive pulmonary disease is one of t he  typical illnesses in t h e  
developed world. I ts  etiology i s  usually described as multicausal. The exact  origin 
of this type of disease during the  life span i s  often undetectable which complicates 
t he  exac t  disclosure of t he  causative factor .  In t he i r  daily pract ice ,  medical doc- 
tors usually only face t h e  full manifestations of clinical symptoms. The relation- 
ship of these manifestations t o  t he  primary causes is  often impossible t o  analyze in 
detail (Bajan 1968). 
Several  epidemiological studies undertaken in various countries have furth- 
e r ed  o u r  understanding of many etiopathogenetic factors in COPD development. 
From the  clinical and pract ical  point of view, i t  i s  possible t o  divide these into four  
categories (Halak and Bajan 1976): 
biological 
physical 
chemical 
allergical. 

All of these fac tors  i r r i ta te  and infiltrate mucosis of the  pulmonary system o r ,  
through the antibody reaction (allergy), p repa re  conditions f o r  the  illness t o  
develop (Ba jan 1983). 
The above categorization of etiopathogenetic fac tors  i s  especially suitable 
f o r  didactic purposes, but in pract ice,  one usually faces the  mixed effects of these 
factors.  The effect of c igaret te  smoke, f o r  example. i s  partly chemical, partly 
physical, and sometimes even allergical, which is why we include the  complex ef- 
fects  of these harmful aspects  in t e r m s  of a r isk factor  in the  model. 
3.1. Risk F a c t o r s  f o r  COPD Deve lopment  
Thanks t o  the  wide dissemination of warnings against smoking, c igaret te  smok- 
ing is generally a recognized factor  in the  development of chronic airways 
diseases. Much less i s  known of the  o ther  COPD risk factors.  
SMOKING: Smoking is undoubtedly foremost in the  etiopathology of COPD. The 
smoker c rea tes  an  even higher contamination of a i r  f o r  himself by inhaling all t he  
polluting substances from the  smoke directly into his o r  h e r  airways. The number 
of harmful substances in cigaret te  smoke i s  given in Sylla (1978) and exceeds 1300 
various kinds. Nicotine alone is a strong enough poison, with lethal doses of about 
50 milligrams f o r  a human being. 
Functional abnormalities of the  lungs are present in a large number of smok- 
ers (Fletcher et al. 1976; Dosman e t  al. 1981; Tashkin et al. 1984). If they continue 
smoking, a significant number of them develop severe  and clinically manifested ob- 
structions of the  bronchial tree. Conclusions from several  long-term prospective 
studies suggest tha t  cessation of smoking (at  an  ear ly s tage in chronic airflow 
development) can prevent progression t o  a clinically significant disease by revers-  
ing the  established, related acceleration in annual decline in the  lung function t o  
o r  toward a normal r a t e  of decline (Fletcher and Pe to  1977; Bosse et al. 1981; Hjal- 
marson and Svardsudd 1981). Smoking significantly increases the  mortality of 
smokers. For heavy smokers (more than 25 cigaret tes  p e r  day), COPD related mor- 
tality is up t o  25 times higher than f o r  nonsmokers (Ferlinez 1974). This fac t  w a s  
demonstrated also by Hammond (1966) in his study of 1 million males and females. 
In Table 2 w e  summarize the  resul ts  of this study and emphasize the  difference in 
mortality between m a l e  smokers and nonsmokers. In the  female population this 
difference w a s  minimal. 
Table 2. Mortality differences in smokers and nonsmokers by sex and age  (Ham- 
mond 1966). 
Number of COPD deaths 
Non-smokers Smokers 
Age Age 
Sex 45-64 65-79 45-64 65-79 
Male 10  10  194 175 
Female 6 - 7 - 
Cigarette smoking acts alone and synergically with the  o ther  r isk factors  of 
COPD. In the  developed countries, i t  is  the  single most significant causal entity and 
i t s  impol-tance is several  times g rea t e r  than a i r  pollution (WHO 1979). 
AIR POLLUTION: People who live in urban areas have a significantly higher 
incidence of COPD than those from r u r a l  a reas ,  as proved several  times in epi- 
demiological surveys. The frequency of illnesses in airways is much higher in the  
inhabitants of towns with extreme a i r  pollution (Holland and Reid 1965). Air pollu- 
tion at the place of work plays a very important role,  with symptoms of distur- 
bances of resp i ra tory  functions being very frequent in miners and in workers in 
dusty environments. Several  studies have proved the  dependence of COPD in- 
cidence on the  length of employment in certain high-risk professions. The resul ts  
of investigation of COPD prevalence in the  nonsmoking population of workers in 
coal/electric power plants, unambiguously support this  fac t  (Stejskal e t  al. 1983). 
The reversibility of t he  effects of this fac tor  w a s  proved in a study of mi- 
grants  from towns with significantly polluted a i r  in Great  Britain t o  towns with less 
a i r  pollution in the  US (Reid and Fletcher 1971). 
A significant degree of a i r  pollution can be achieved by smoking in closed 
rooms. Nonsmokers, being present  in such a n  environment, inhale cold cigaret te  
smoke with all the  dangerous constituents, a phenomenon usually called passive 
smoking. Children with parents  who smoke appea r  t o  have small, but measurable, 
differences in a test of lung function. These children also have an  increased f re -  
quency of bronchitis, pneumonia, o r  o the r  respiratory symptoms, when compared 
t o  children from homes with nonsmoking parents.  
INFECTION: Despite the  fac t  tha t  infection is not among the  leading causes of 
COPD, i ts  role  in the  increase and development of the  sickness is generally recog- 
nized and proved (Tager and Speizer 1975). The role  and significance of bacterial  
and viral  infection, from the  etiopathogenetical point of view, is demonstrated not 
only in the  origin of,  but also in t he  maintenance of the chronic cha rac t e r  of the  
COPD process. Several authors  s t r e s s  the  significance of infections of the  lower 
respiratory t r a c t  in childhood (Holland et al. 1969; Reid 1969). They take into 
consideration the  higher sensitivity in these children t o  the  development of COPD. 
According t o  the resul ts  of a study of 2228 schoolboys between the  ages of 7 and 11 
years  (from South Wales and West England), up t o  10% of the  boys and 6% of the  
girls had infected airways. In t he  majority of these children, significant impair- 
ment of lung functions w a s  found (Yarnell and Leger 1981). 
ALLERGY: These fac tors  present independent and, until now, ambiguously 
solved problems. Despite plenty of new evidence, t he re  is no known mechanism 
tha t  can explain the  complex of changes tha t  lead t o  the  final state of i r reversible  
obstructive changes on the  basis of atopy alone (Orie and von d e r  Lende 1970; 
Schmidt 1979). 
AGE: In connection with the  etiological factors  tha t  affect t he  development of 
COPD, i t  is  necessary t o  mention one more very important factor-age. COPD fre-  
quently occurs  in the  older age  category of t he  population. Conditions f o r  the  on- 
set of the  manifestation of COPD crea te ,  besides o the r  factors ,  physiological, 
s t ructural ,  and pathophysiological changes in the  lungs and in t he  bronchial t r e e  
during the  la te r  phases of life, as well as a general decrease of resistance. 
GENETICS: In the  ear ly 1960s, scholars announced a new syndrom--alpha 1 
protease inhibitor deficiency being genetically t ransfer red ,  later known under the  
term alpha 1 antitrypsin deficiency (Laurel and Eriksson 1963). Later  on, the  re -  
lationship between this disorder and a significant increase in the  size and reduc- 
tion of the  number of alveoli, a diminution of t he  internal lung surface, and a rear- 
rangement of the  lung tissue was stated (Snider and Korthy 1978). I t  is more than 
probable tha t  these mechanisms play an  important role  in the  course of COPD 
(Snider 1984). 
ALCOHOL: Burch and DePasquale (1967) hypothesized the  existence of an  "al- 
coholic lung disease" and Rankin called attention t o  t he  high prevalence of airways 
obstruction in alcoholics who also smoke (Rankin e t  al. 1969). Indeed, heavy al- 
cohol consumption is associated with chronic cigaret te  smoking in a large number 
of epidemiologic surveys. The association of heavy drinking with increased cough- 
ing, excessive mucous hypersecretion, and frequent episodes of non-specific 
respiratory illnesses has  led numerous investigators t o  speculate tha t  alcohol exa- 
cerbates  the  effects of smoking and contributes t o  the  development of chronic 
bronchitis (Lebowitz 1981; Krumpe et al. 1984). Despite all  of the  research  being 
done in this field, t he  question still remains open. 
Etiopathogenetic fac tors  of COPD represent  a complicated se t  of agents of ex- 
ogenous o r  endogenous charac te r .  They cooperate in t he i r  originating changes in 
the  bronchial tree and in creating the  conditions f o r  the  individual forms and 
features  of COPD manifestation. There a r e  still many open and unsolved questions 
in the  etiopathogenesis of COPD, despite the  evident progress  of research  into the  
effects and influence of different COPD risk factors.  N e w  discoveries in this field 
will not only have a theoretical impact, but also a significant impact on prevention. 
ear ly diagnosis, and effective therapy. 
4. COPD MODEL OBJECTIYES 
Health care statistics adequately describe the  prevalence of tuberculosis, 
venereal diseases, and communicative diseases in a majority of countries. This is 
because when medical statistics were developed, tuberculosis and infectious 
diseases were t he  most important health problems. This conjunction of medical 
statistics and infectious diseases is described in the curriculum vitae of Florence 
Nightingale, who helped t o  pioneer the  revolutionary notion that  social phenomena 
could be  objectively measured and subjected to mathematical analysis (Cohen 
1984). Besides this historical relationship, t he re  is another  fea ture  of routine 
medical statisitics: the  majority of them are episode based (case based), not based 
on the individual (Zacek 1984); modern health c a r e  calls f o r  knowledge of the 
la t te r  type of information. The prevalence image is governed by chronic, noncom- 
municable diseases. However, no cu r r en t  routine source of medical information 
treats the whole history of the  development of a chronic disease from i ts  onset un- 
til i ts  end. Thus, health care managers frequently do not know the prevalence of a 
particular illness in the  population. However, they must have this knowledge in 
o r d e r  t o  effectively fight against the  illnesses. 
Prevalence studies are often used t o  examine occurences of chronic diseases, 
involving a limited proportion of the  population who suffer from a part icular  
disease, disability, syndrome o r  studied symptom within a shor t  period of time. Of 
' course,  such surveys a r e  usually very expensive, which is why they a r e  res t r ic ted  
in time and a r ea .  The description of t he  allocation of a number of sick people is 
t he  usual resul t  and such information is  of g r ea t  value fo r  health care manage- 
ment. However, i t  i s  insufficient f o r  the  purpose of setting objective ta rge ts  and 
procedures  f o r  t he  health c a r e  system and fo r  short-  and long-term planning, 
especially the latter. 
In a r ecen t  paper ,  w e  drew attention t o  t he  possibilities of using mathematical 
modeling to transform s ta t ic  information--which has been accumulated by means of 
different surveys--into a dynamic tool in the  hands of health care managers 
(Koonce et al.  1984). During the  designing of t he  COPD model, w e  have kept  in mind 
this target .  The design is  based on understanding the  cu r r en t  situation and defin- 
ing ou r  aims. The general aim, remaining a f t e r  all  of o u r  efforts,  i s  to decrease  
t h e  prevalence of COPD. To fu r the r  this, t h e  model can aid t h e  task of discovering 
the  effects of different r i sk  fac tors  on COPD prevalence diminution. There is  
probably no need f o r  explaining tha t  i t  has, besides t h e  ethical consequences. such 
a diminution would have a ser ious economic effect with r e spec t  to t h e  whole of so- 
ciety. The model also follows this  aspect  of health care. 
W e  assume tha t  a f t e r  some time the  model will find i ts  place within t he  system 
of continuous health-care development forecasts.  Even more, w e  suggest tha t  this  
model could be  used in postgraduate training of health care managers at different 
levels. Research into COPD could prof i t  from utilizing this model as well. 
5. COPD MODEL STRUCTURE 
The COPD prevalence model consists of t w o  majo r  blocks of logic: 
prognosis f o r  population development 
prognosis f o r  t he  development of COPD risk fac tors  development. 
The possibility of testing different scenarios allows a holistic approach t o  t h e  
model. 
5.1. Population Development Prognosis 
The forecas t  is  based on a simplified view of population development. Data f o r  
the  demographic prognosis are estimated from the  number of newborns, t h e  
number of all deaths,  and t h e  number of transitions between age groups. Such fac- 
t o r s  as migration, male/female rat io ,  and s o  on, were not considered in t he  fore-  
- 11 - 
cast.  The overall  prognosis is based on data from Slovakia, 1983. 
5.2. COPD Risk Factors Prognosis 
This module represents  the  key point of the whole model. We have employed 
ou r  knowledge of COPD etiopathogenesis in this a r ea .  The whole model construc- 
tion is according to  the  following th ree  population divisions: (1) healthy individu- 
als, (2) those in COPD risk,  and (3) those suffering from COPD. 
HeaLthy IndividuaLs: We define the members of this group as those individu- 
als  without COPD symptoms and those not under t he  influence of any of the  risk fac- 
tors.  We ignore the  possibility of genetic t ransfer  of COPD, which means that ,  from 
our  point of view, all newborns a r e  healthy, having the same probability of staying 
healthy o r  entering any of the risk groups. 
IndividuaLs w i t h  COPD Risk Factor: W e  begin from the  point of view of the  
model ta rge ts  in analyzing the  problem of risk group selection. The only ones we 
selected were those with important etiopathogenesis and the  real possibility f o r  in- 
tervention by a health c a r e  system o r  society. That i s  why w e  chose the  following 
factors:  
smoking: one of the  most important factors ,  influencing the  largest  p a r t  of 
the  population, but t he  effect  of intervention by health c a r e  o r  society is sti l l  
dubious. 
air poLLution: compared with smoking this fac tor  i s  of secondary impor- 
tance. The ro le  of securing a diminution o r  even elimination of this is of pri- 
m a r y  importance. 
f requent  r e sp i r a to ry  infections: t he  role  of this  fac tor  in the  development 
of COPD in adulthood is still not clearly defined. In t he  struggle against this 
fac tor ,  the last word has not yet  been said. 
COPD s ick  individuaLs: Individuals who fulfil t he  WHO cr i te r ia  f o r  chronic 
bronchitis, lung emphysema, o r  bronchial asthma were placed in this  group (WHO 
1980). 
The overall  model s t ruc ture  i s  shown in Figure 2. 

6. COPD MODEL REALKZATION 
6.1. Model Der ivat ion  
The p a r t  of the  COPD model tha t  describes population dynamics is based on the  
concept of people flow from one age category t o  another  in each year .  A certain 
number of people a r e  born and a certain number die. Denoting as n l ( t )  the  
number of people in the group aged younger than 20 years ,  b ( t )  t he  number of 
newborns, and j+ t he  death r a t e  f o r  the  f i r s t  age  category in yea r  t ,  one can 
describe the  population as follows: 
n l ( t )  = n l ( t  -1) + b ( t )  - 0.05nl(t -1) - h n l ( t  -1) . (1) 
The constant 0.05 represents  that  p a r t  of the  population which en te r s  the  next age 
group (20-year age groups in this case). We do not have newborns in the  older 
ages, but instead we have an  inflow of people from the previous age  groups. Be- 
cause we have 20-year age  groups w e  use the  0.05 constant again. 
W e  have only one transition from the last  group, s o  w e  can write the  equation as 
follows: 
The second p a r t  of t he  COPD model describes the dynamics of the  population 
under different risk factors.  A s  already mentioned, the  people not subjected to  
ex t r a  risk of COPD development were considered as a special type. Denoting j f o r  
the age categories,  one can describe this group as follows: 
Assuming four  age categories,  we have j = 1 ,  . . . , 4. For those under 20 years  of 
age, p denotes the  number of newborns. For o thers  i t  denotes the  p a r t  of the  po- 
pulation tha t  en ters  the category from the previous one: 
People from this group may en te r  one of the o ther  risk groups, become ill from 
COPD, or even die. The process of transition to other  health hazards is represent- 
ed by the  sum of the  transition coefficients p 
The possibility of t he  onset of a COPD disease in healthy individuals is depicted by 
the coefficient A!. The number of people dying in this group from causes o ther  
than COPD is: 
when stands fo r  mortality ra te .  
Applying similar notation, one can derive equations for  estimating the  number 
of cigaret te  smokers: 
1 1  2 2 n:(t) = n;(t -1) + p nj ( t )  + p - Aj nj ( t  -1) - 0.05nf(t  -1) - zjn:(t -1) 
the  number of people in an air-polluted environment: 
2 1 n;(t) = n;(t -1) + p nj ( t )  + p - A?n;(t -1) - 0.05nf(t  -1) - -,nf(t -1) 
and the  number of children with frequent respiratory infections: 
3 1 4 4 n:(t) = n:(t-1) + p nl ( t )  - A,n,(t -1) -0.05n:(t-1) -&n:(t -1) . (11) 
Since the  aim of the model is to estimate the  number of people with COPD, the  
following equation w a s  derived: 
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t o  depict t he  COPD prevalence dynamics. 
6.2. Implementation 
The following items were used f o r  t h e  initialization of t he  forecast :  
age  s t ruc tu re  of the  population of t h e  Slovak Socialistic Republic (SSR), 
1983; 
general death r a t e  fo r  population of SSR, 1983; 
number of newborns in SSR, 1983; 
number of COPD related deaths  in SSR. 1983; 
risk of COPD in individuals in SSR, 1983, with and without r isk factors ;  
COPD risk-factor prevalence in t h e  population of SSR, 1983; 
coefficients of transition from the  group without r isk to t h a t  with r isk;  
average  length of s tay  in t he  hospital f o r  a patient with COPD; 
coefficient of transition from t h e  group of COPD ill to disabled; 
average number of days in sanatoriums. 
W e  divide t h e  population into four  groups according to age: 
0-19 years ;  
20-39 years ;  
40-59 years ;  
60 yea r s  and over.  
W e  are aware of t h e  error possibly arising from this  rough a g e  stratification, 
but res t r ic t ions due to t h e  computer used did not allow us to probe this  problem 
more deeply. The same situation occurs  in t h e  sex  s t ruc ture .  The following may 
support  o u r  decision not to consider sex  differences: in developed countries 
smoking s ta r ted  as a predominantly male phenomenon and women s ta r ted  to smoke 
much la te r .  While men were usually the  f i r s t  to stop smoking, smoking continued to 
increase among women (although i t  has  now s ta r ted  to level off, apparently as a 
resul t  of smoking control activities) at a much lower rate than tha t  reached by men 
(WHO 1979). S o  w e  t r i ed  to select data describing the  whole population regardless  
of sex. 
In o u r  model design, w e  employed the assumption tha t  each of the  r isk factors 
affects  t he  population independently. W e  abstracted t he i r  synergistic effects,  
having in mind t h e  following ranking: 
(1) smoking 
(2) a i r  pollution 
(3) frequent resp i ra tory  diseases in childhood. 
So, if an individual is  a smoker, i t  i s  possible to neglect t he  influence of o the r  con- 
taminating factors .  Similar hypotheses were also accepted f o r  t he  o the r  combina- 
tions of factors ,  since t he  lack of data on the  effects of the  combinations of r i sks  
forces  this  simplification. 
W e  implemented the  COPD model on an  APPLE-IIe microcomputer in APPLESOFT 
BASIC. The program is  assembled from several  modules, as shown in Figure 3. Data 
specifying the  s tar t ing conditions of t he  model are incorporated into the  program 
by means of t he  command DATA. 
6.3. Demographic Data 
The demographic data  f o r  t he  SSR population (age s t ruc ture ,  death rate, 
newborns) were ext rac ted  from t h e  Sta t i s t i ca l  Health Care  Year Book f o r  
Czechoslovakia (CSSR zdravotnictvi 1983)*. Specific mortality fo r  COPD w a s  
derived from a stat is t ics  book (Pohyb obyvatelstva v SSR, 1983). The number of 
COPD deaths is  not enumerated in this  book, which i s  why w e  considered the  sum of 
deaths  from following diagnostic categories,  according to t he  Internat ional  Clas- 
s i f i c a t i o n  o f f i s e a s e s  (VIII-th revision): 
ICD 491 chronic inflammation of bronchi-chronic bronchitis 
ICD 492 lung emphysema 
ICD 493 bronchial asthma. 
There are t h r e e  types of mortalities considered in this  model: overall  mortali- 
ty,  specific COPD mortality, and mortality without COPD. This distinction w a s  em- 
ployed par t ly  t o  verify t h e  different effects on mortality and par t ly  because of t h e  
possibility of extending t h e  model to o the r  diseases. 
*These data a r e  included in  Table 3. 
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Figure 3. The COPD model realization in computer program. 
Table 3. Population, number of deaths without COPD, and number of deaths from 
COPD (Pohyb obyvateslstva v SSR 1983). 
Initial demographic data  fo r  Slovakia, 1983 
Age group Population in SSR Deaths without COPD COPD deaths  
0-19 1736000 3342 1 
20-39 1619000 1912 7 
40-59 1070000 6735 123  
60- 731000 33269 1760 
6.4. Number o f  COPD Cases 
There are two main channels of information about general morbidity data: 
routine statist ics 
special investigations 
Most countries do not supply routine data  on COPD prevalence (Shigan 1977). How- 
eve r ,  the  data  do descr ibe hospitalizations, sick-leave cases and days, disease 
specific mortality, and o t h e r  indirect measures of prevalence. The most appropri-  
ate source of prevalence da t a  are special  investigations. W e  based the  estimation 
(of t he  initial COPD prevalence in t he  SSR) on t h e  resul ts  of a study of 20000 inha- 
bitants, 15 yea r s  and older ,  in the  Danube area (Virsik et al. 1976) along with an  
investigation of about 60000 people (male and female) in t he  West of Slovakia (Kru- 
ty et al. 1975). For a more precise  estimation of prevalence, w e  plan an  extension 
of t he  model with a module of prevalence estimation based on some indirect pre-  
valence indices. The values of t he  initial COPD prevalence are summarized up in 
Table 4. 
6.5. Risk o f  D e v e l o p i n g  COPD 
W e  consider t h e  estimation of coefficients-for expressing the  r isk of COPD 
development in an  individual sor ted  by r isk factors--to be  of crucial  value f o r  the  
success of t he  model. The way tha t  w e  perceive t he  r isk considers t he  pathogenic 
power of the  etiology fac tor ,  which means the magnitude of risk f o r  an individual 
Table 4. Initial COPD prevalence in Slovakia, 1983. 
Age Number of cases 
subject to one of t h e  fac tors  tha t  increases t he  likelihood of developing the  con- 
sidered disease. According to Zacek (1984), t h e  measure of r isk is  according t o  
the  magnitude and duration of t he  association. Mathematical statist ics o f fe r  a 
number of different techniques f o r  establishing this (Armitage 1971). Case-control 
and cohort  studies are used to measure t he  increased r isk of incurring a particu- 
lar disease if a cer ta in  fac tor  is  present.  In cohort  studies, such estimations can  
be  done directly by observing t h e  experience of groups of subjects with and 
without t h e  fac tor .  In a case-control study the  da ta  do  not present  an  immediate 
answer t o  this  type of question. The association between the  fac tor  and the  
disease could be measured by the  ra t io  of t he  r i sks  of t h e  disease being positive 
f o r  those with and those without t he  factor .  
W e  processed coefficients of re la t ive COPD risk according to data  from COPD 
epidemiological studies ca r r i ed  out in t he  SSR during r ecen t  years.  Because w e  
could not find a survey of t he  consequences of all t h r e e  r isk fac tors  used, w e  com- 
bined data  from severa l  sources.  Numerous surveys were conducted to compare 
t he  incidence and r isk of COPD in t he  inhabitants of r u r a l  and urban areas (Olejni- 
cek et al. 1974; Kubik et al. 1978; Coufal et al. 1973). W e  solved the  question of 
COPD incidence in youths with t he  help of a study oriented selectively on younger 
age  categories  (Vyslouzil et al. 1975). For t h e  r isk of COPD development in indivi- 
duals with frequent resp i ra tory  infections during childhood w e  used the  resul ts  of 
t he  study on t h e  population of South Wales and the  West of England (Yarnell and 
Leger 1981), because w e  do not know of any such survey in Slovakia. Table 5 con- 
tains values of coefficients used. 
Table 5. Risk of COPD onset f o r  people under different r isks ,  by age. 
Age 
Risk group 0-19 20-39 40-59 60- 
Without risk 0.02 0.1 0.2 0.25 
Smokers 0.05 0.3 0.6 0.75 
Air pollution 0.1 0.2 0.25 0.3 
Respiratory infections 0.39 0 0 0 
6.6. Risk Factors Prevalence 
The estimation of risk-factor incidences in t he  population could, at f i r s t  
glance, be  regarded as an  easier  task compared t o  previous ones, but w e  have t o  
state rational limitations t o  be successful. There a r e  a large number of surveys 
tha t  consider t he  distribution of smokers in the  population. Different c lusters  of 
smokers a r e  used according to,  e.g., what is smoked, f o r  how long, how deeply the  
smoke is inhaled, e tc .  W e  made use of the following stratification of people ac- 
cording t o  the i r  smoking habits: 
smokers 
nonsmokers 
W e  restr ic ted o u r  attention t o  cigaret te  smoking alone. W e  received some 
valuable data on smoking from the  Special Study of Tobacconism in Slovakia (Ka- 
t r iak 1983). They investigated the  smoking habits of 1700 inhabitants of the  SSR 
14 years  and older,  chosen at random according to sex,  age, social status,  and 
residential area. The study represents  a complex view on smoking epidemiology in 
the  SSR. 
More problems were faced in estimating the  number of people affected by pol- 
luted a i r .  For Slovaks living in areas with good quality a i r  and f o r  those living in 
towns with proved a i r  pollution, no appropriate  data  were found. W e  understand 
tha t  this division is too general, but until be t te r  data  i s  available w e  can use noth- 
ing else. The data  on a i r  pollution were estimated according t o  Kiihnl (1982). 
The frequency of respiratory diseases in children is about 3-4 illnesses p e r  
year ,  but is usually less frequent f o r  children in ru ra l  areas. W e  estimated the  
number of children with frequent respiratory infections with the  help of a 
pediatrician's expe r t  estimation. Our opinion, based on experience with this data  
estimation, i s  t ha t  no more p rec i se  da t a  on t ha t  problem will b e  available in t h e  
n e a r  future .  The proport ions  of people subject  t o  di f ferent  r i sks  are summarized 
in Table 6. 
Table 6. Proport ions  of people subject  t o  different r i sk  f a c to r s  by age .  
- A g e - - -  
Risk group 0-19 20-39 40-59 60- 
Smokers 0.144 0.277 0.245 0.07 
Air pollution 0.273 0.161 0.130 0.045 
Respira tory infections 0.264 0 0 0 
6.7. T r a n s i t i o n  C o e f f i c i e n t s  B e t w e e n  G r o u p s  
These coefficients descr ibe  how an  individual subject  t o  none of t h e  mentioned 
health r i sks  can e n t e r  one of t h e  r i sk  groups. Derivation of these  coefficients is  
based on t h e  assumption t ha t  a newborn child i s  under no r i sk ,  which excludes t h e  
possibility of hered i ta ry  defects.  Numbers f o r  transit ions to t h e  group of smokers 
were derived from t h e  a l ready mentioned study of c igare t t e  smoking epidemics in 
Slovakia (Katriak 1983). The estimation of coefficients f o r  air pollution w a s  done 
using migration da t a  f o r  Slovakia (Kiihnl 1982). Because of t h e  lack of s ta t is t ical  
da t a  on children's  r e sp i r a to ry  infections, expe r t  opinions were used. The expe r t s  
(physicians) were familiar with t h e  epidemiological situation among t h e  children in 
Slovakia. Table 7 comprises t h e  descr ibed coefficients f o r  Slovakia. 
Table 7. Coefficients of t ransi t ions  between t h e  group of people with no mentioned 
health hazard compared t o  those  with hazard.  
Age 
Risk group 0-19 20-39 40-59 60- 
To smokers  50 30 30 30 
To air-polluted areas 0.025 0.06 0.06 0.165 
To r e sp i r a to ry  infections 0.08 0 0 0 
7. RESULTS AND DISCUSSION 
The COPD model allows the  user  t o  forecast  the  prevalence development t o  t h e  
year  2003 (20 years  forecast) .  Figure 4 depicts t h e  basic development of pre-  
valence, when no interventions are assumed. Notice t h e  steady increase in quanti- 
ty of sick people, especially in age categories, which. should s t r ike  t he  attention 
of health care managers and policymakers. 
Several  scenarios were used t o  test different approaches and the i r  impacts 
on the  population. The transformation of an  exper t ' s  ideas into scenarios 
represen ts  a quantification of t he  hypothesis, and i t  i s  possible t o  express  such a 
quantification in severa l  different ways. The model uses percentages as a measure 
of change between the  original state and the  hypothetical situation. The change 
could be  introduced in any y e a r  of t he  forecasted period. 
Tested hypotheses w e r e  chosen in o r d e r  t o  highlight t h e  answers t o  these 
questions: 
how would a change in t he  amount of people affected by different r i sks  influ- 
ence COPD prevalence in t he  future? 
how would t h e  prevalence react t o  a change in more effective COPD therapy 
and prevention? 
Figures 5 and 6 depict situations in which different changes in t h e  smoking si- 
tuation are assumed. The hypotheses of reducing the  number of smokers and of in- 
creasing the  smoker population were tested. Reducing t h e  amount of people af- 
fected by c igare t te  smoke has  long been a task of many, not necessarily health 
care, authorit ies all ove r  t he  world, with several  programs of WHO and o the r  insti- 
tutions trying t o  treat this problem. US smoking habits are shown in Table 8. 
Column (1) of Table 8 shows tha t  t he  total  US c igare t te  consumption has  in- 
creased fairly steadily over  t h e  past  t w o  decades, but t h e  growth in total  consump- 
tion has  not kept  pace  with t he  growth in t h e  smoking population. This is  ref lected 
in column (3) in which t h e  aggregate  da ta  are converted into cigaret tes  p e r  adult 
(individuals over  1 7  years  of age). A s  columns (3) and (4) show, by this measure 
cigaret te  consumption has  fallen steadily, if gradually, since 1973 (Warner 1983). 
Figure 5 shows t h e  prevalence change a f t e r  t h e  effective antismoking cam- 
paign w a s  introduced (dimunition of smokers t o  80% in people younger than 20 
years  and t o  70% between 20-39 years  of age in t he  yea r  1985). 

Table 8. Total and adult p e r  capita c igaret te  consumption by yea r  (Warren 1983). 
Total  consumption Percentage increase  Percentage increase  
(bi l l ions  of (decrease)  from Consumption (decrease)  from 
c i g a r e t t e s )  preceding y e a r  per adult preceding y e a r  
Year (1) (2) (3) (4) 
The awaited effect  of dimunition of COPD cases  w a s  not as significant as one 
might have hoped. Nevertheless, a decrease of 1000 COPD sick people in t h e  
younger age  groups will have a more significant effect  on t he i r  health when they 
become older.  Practically no change w a s  achieved in t he  older age categories,  
which ref lects  t he  time delay required f o r  -an individual from one age  group to 
reach  the  older  age  category. A s  w e  have 20-year age  groups, only a half of t h e  
population will reach  the  older  age groups during t h e  forecasted period (10 
years).  
The scenario with increasing numbers of smokers in two younger-age 
categories w a s  tested (the number of people younger than 20 years  who start 
smoking is  increased by 140% and tha t  of people between 20-39 yea r s  of age  by 
130% of t he  1985 figures). The resul ts  were just t he  opposite to those derived from 
the  f i r s t  scenario,  as shown in Figure 6. 
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The most affected population would be in the  younger-age categories.  The hy- 
pothesis used ref lects  a situation tha t  is  common in nearly all  t he  developed coun- 
t r ies .  The number of heavy smokers among men in twenties and the i r  thir t ies  in- 
creased,  but t h e  number among older men decreased. The number of female heavy 
smokers, on t h e  o the r  hand, has  continued to increases until women were in t he i r  
fifties (Stoto 1985). 
Another two scenarios tested t he  situations in which substantial changes in 
COPD prevention and treatment effectiveness occur.  Screening fo r  initial lung 
function impairments and complex treatment of acute  upper  resp i ra tory  infections 
together  with decreasing a i r  pollution, are t he  main possibilities f o r  preventing 
COPD illness. Figure 7 ref lects  t he  situation with increased effectiveness of 
preventive programs. The usual t a rge t  of such programs is  t h e  adult p a r t  of t he  
population--up t o  60 years  of age. The hypothesis employed suggests t he  r i s e  in 
prevention effectiveness will be  140% in t he  age groups 20-39 and 40-59 years .  The 
response of t he  model w a s  immediate. The change w a s  introduced in 1984 and a sig- 
nificant decrease  in COPD prevalence appeared during t h e  same yea r  in the  second 
and third age categories and a f t e r  four  years  in t he  older age categories. 
Assuming tha t  t h e  health authorit ies will not pay appropr ia te  attention t o  t he  
preventive activities, t h e  hypothesis of a decline to 60% of t h e  cu r r en t  s ta tus  in 
the  same age groups as t h e  previous scenario w a s  tested. The change w a s  intro- 
duced in 1984 and t h e  resul ts  of t h e  forecas t  are shown in Figure 8. 
CONCLUSIONS 
More hypotheses than mentioned h e r e  were checked, most striking resul ts  be- 
ing given as examples of the model's runs.  The described model is  one of t he  f i r s t  
s teps  in ou r  effor ts  t o  model sociodemographic impacts of chronic diseases on po- 
pulations. The results showed us what w e  should use in fu ture  population models. 
Based on t h e  experiments with t h e  model, t h e  following conclusions can be  
drawn: 
t he  model provides t h e  experimentor with meaningful forecasts  and enables 
him o r  h e r  t o  test different types of scenarios; 
t h e  COPD model is  sensitive enough to simulate assumed changes; 
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the  data  aggregation by four  age groups seems t o  us t o  be  too coarse ,  
disaggregation into more age  groups and by sex would probably bring be t te r  
insights into t he  system dynamics; 
t he  disaggregation would certainly requi re  more computer memory than 64 K 
bytes and the  use of some compilor seems t o  be  necessary, because of the  in- 
creased time f o r  computation; 
the  interactive,  user-friendly mode of t he  model's operation allows i ts  utiliza- 
tion by those unskilled with computers. 
The incomplete information on COPD prevalence and on the  transitions 
between different population groups does not allow to use t he  traditional model- 
tuning procedures.  The resul ts  of modeling, however, were discussed with exper t s  
in COPD, whose opinion was tha t  the  model i s  realist ic and can help in understand- 
ir\g the  mechanisms of COPD development. The new da ta  on various aspects  of COPD 
will allow us to develop a more detailed version of the  model. 
Based on these facts ,  t he  new version of this model i s  under preparation. The 
authors  hope tha t  i t  will be  of substantial help t o  o ther  scholars  in this field. 
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Appendix: Program Listing 
5 REM NEW VERSION DF COPD PROGR 
AM 
10  REM I IASA  NOVEMBER 2 6 , 1 9 8 4  
2 0  D I M  P ( 2 1 , 4 >  ,M1 (4>  ,M2(4>  , N 5 ( 2 1  
, 4 >  , U ( 2 0 >  
3 0  D I M  L1(4,4>,N(4,4>,R1(3,4>,Nl 
( 2 1 , 4 >  , N 2 ( 2 1 , 4 >  , N 3 ( 2 1 , 4 >  ,N4( 
2 1 , 4 >  
3 1  D I M  D 4 ( 4 >  ,M(4> 
33 D I M  MX(4 )  ,RX(3 ,4>  , L X ( 4 >  
3 5  FOR I = I TO 4 : M X ( I >  = 100 :LX  
(I> = 1 0 0 :  NEXT I 
36 FOR I = I TO 3: FOR J = I TO 
4 : R X ( I , J >  = 100 :  NEXT J: NEXT 
I 
40 A = FRE ( 0 ) :  PRINT "VOLNA PAM 
AT:"  ;A 
50  REM ........................ 
--- 
5 1  REM P ( T ,  J> SLOVAK POPULATION 
BY AGE 
5 2  REM B NUMBER DF NEklBORNS I N  
SSR 1 9 8 3  
5 3  REM M 1 ( J >  COPD MORTALITY I N  
SSR 1 9 8 3  
5 4  REM M 2 ( J >  GENERAL MORTALITY 
WITHOUT 
55 REM COPD CASES I N  SSR, 
1 9 8 3  
5 6  REM U ( T >  % OF CHANGE I N  MORT 
A L I T Y  
57 REM I N  FORCASTED YEARS 
58 REM N (  I , J> PROPORTI ON OF SLO 
VAK POPU 
59 REM LAT ION I N  R ISK  
6 0  REM 1=1 WITHOUT R I S K  ' 
6 1  REM 1=2 CIGARETTES SMOKING 
6 2  REM 1=3 L IV INGAJORKING I N  
A 1  R-POLL 
63 REM UTED ENVIRONMENT 
6 4  REM I = 4  FREQUENT LIPPER-A1 R 
WAYS I N  
65 REM FECTI  ONS 
66 REM R L ( I , J >  COEF.OF TRANSIT1 
ON FROM 
67 REM GROUP WITHOUT AN 
Y R ISK  
6 8  REM TO THE R ISK  GROU 
PS 
6 9  REM 1=1 SMOKING 
7 0  REM 1=2 INFECT1 ONS 
7 1  REM I = 3  AIR-POLLUTION 
7 2  REM L l ( 1 , J ) R I S K  OF GETTING S 
I C K  FROM 
7 3  REM COPD FOR PEOPLE 
7 4  REM 1=1 WITHOUT R ISK  
75 REM 1=2 C I  GARETTES SMOKING 
76 REM 1=3 INFECTIONS 
77 REM I = 4  AIR-POLLUTION 
78 REM N l ( T , J >  FORECAST OF PEOP 
L E  WITH0 
79 REM OUT R ISK  
8 0  REM N 2 ( T , J >  FORECAST OF W O K  
ERS I N  
8 1  REM SSR 
8 2  REM N 3 ( T , J )  FORECAST OF PEOP 
L E  WITH 
83 REM FREQUENT INFECT1 
ON S 
8 4  REM N 4 ( T ,  J> FORECAST DF PEOP 
L E  I N  
85 REM A 1  R-POLLUTI ON 
86 REM T T I M E  OF FORECAST I N  YE 
ARS 
37 REM J AGE GR0UPS:O-19;20-39; 
40  -59 ; 
88 REM 60&MORE 
9 0  REM MX( I > 1=4 FACTOR TO C H W  
GE MORTALITY 
9 1  REM RX( I > 1=4 FACTOR TO CHAN 
GE TRANSIT ION INTO R ISK  GROU 
PS 
92 REM LX( I > 1=4 FACTOR TO CHAN 
GE TRANSIT1 ON INTO GROUP OF 
ILL 
1 0 0  REM ........................ 
--------- 
1 0 5  PRINT "TEST SCENARIOS?(Y/N>" 
;: INPUT SCB: I F  MID% (SC8, 
1 , 1 )  = " Y n  THEN GOSUB 4 0 0 0  
1 1 0  DATA 1 7 3 6 , 1 6 1 9 , 1 0 7 0 , 7 3 1 :  REM 
SLOVAK POPULATION I N  1 9 8 3  I 
N THOUSANDS 
1 2 0  FOR I = 1 TO 4 :  READ P ( l , I > :  
1 2 2  N 1 ( 1 , 1 >  = P ( 1 , 1 >  * 0 .51 :  FOR 
I = 2 TO 4 : N l ( l , I >  = P ( 1 , I )  * 
0 . 3 4 :  NEXT I: REM I N I T I A L  N 
UMBER OF PEOPLE WITHOUT ANY 
R I S K  
1 2 5  REM PRINT  TAB( 7 > ; P ( l , l > ;  TA 
B ( 2 2 > ; P ( 1 , 2 > ;  T 
130  B = 1 1 2 7 5 0 :  REM #OF BIRTH I N  
1 9 8 3  
1 4 0  REM MI-#OF COPD DEATHS;M2-# 
TOTAL # OF DEATH WITHOUT COP 
D CASES 
150  DATA 167 ,96 ,336 ,1663 :  REM 
#OF COPD DEATHS 
160  FOR I = 1 TO 4: READ M l ( 1 ) : D  
5 ( I )  = M l ( I > : M l ( I >  = M l ( I >  / 
P ( 1 , I ) :  NEXT I 
1 6 1  REM D5( I) - NUMBER OF DEATH 
S FROM COPD I N  AGE GROUPS 
1 7 0  DATA 3342 ,1912 ,6735 ,33269 :  REM 
NUMBER OF ALL DEATHS 
180 FOR I = 1 TO 4: READ M 2 ( I > : D  
4 ( I >  = M 2 ( I ) : M 2 ( 1 >  = M 2 ( I >  / 
P ( l , I > : M ( I >  = M 2 ( I >  - M l ( I > :  
NEXT I 
190  REM ----- CYCLE TO COUNT POP 
ULATION FORECAST-------- 
1 9 2  DATA 0 .99 ,1 ,1 ,1 .01 ,1 .01  , 1 . 0 2  
,1.02,1.02,1.02,1.03,1.03,1. 
0 3 , l  . 03 ,1  .04,1 . 04 ,1  . 04 ,1  .04 ,  
1 . 0 4 , l  . 04 ,1  . 0 4  
1 9 4  FOR I = 1 TO 20:  READ U( I > : NEXT 
I: REM %OF MORTALITY DEVELO 
PMENT FORECAST 
2 0 0  FOR J = 2 TO 21 :  REM 2 0  YEA 
RS FORECAST 
2 0 2  I F  MY = J THEN FOR K = 1 TO 
4 : M l ( K >  = M l ( K )  * MX / 100 :  NEXT 
K 
2 1 0  P ( J , l >  = P ( J  - 1 , 1 >  + B - ( 0 .  
0 5  * P ( J  - 1 , 1 > >  - ( M 2 ( 1 >  * 
U ( J  - 1 )  + ( M 1 ( 1 >  * X / 1 0 0 )  
> * PC J - 1 , 1 > :  REM POPULA 
T I O N  I N  AGE 0-19  
2 2 0  FOR K = 2 TO 3: REM FOR THE 
2ND AND THE 3RD AGE GROUP 
2 3 0  P ( J , K >  = P ( J  - 1 ,K) + ( 0 . 0 5  * 
P ( J  - l , K  - 1 ) )  - ( 0 . 0 5  * P(  
J - 1 , K ) )  - (M2(K)  * U ( J  - 1 
) + M 1 ( K > >  * P ( J  - 1 , K ) :  NEXT 
K 
240  P ( J , 4 >  = P ( J  - 1 ,4 )  + ( 0 . 0 5  * 
P ( J  - 1 , 3 1 1  - ( M 2 ( 4 >  * U ( J  - 
1 )  + M l ( 4 )  * X / 1 0 0 )  * P ( J  - 
1 , 4 > :  REM POPULATION I N  A 
GE 60 & OVER 
2 4 2  REM PRINT TAB( 7 ) ; P ( J , 1 > ;  TA 
B (  I 2 2 > ; P ( J , 2 > ;  T 
AB( 3 8 > ; P ( J , 3 ) ;  
TAB( 4 8 )  ;P( J , 4 >  
2 5 0  NEXT J 
2 6 0  DATA 1 4 3 , 2 9 8  ,276 ,382 :  REM 
#OF COPD CASESIN SSR I N  1 9 8 3  
2 7 0  FOR I = 1 TO 4:  READ N5( 1 ,  I ) 
: N 5 ( 1 , 1 >  = N 5 ( 1 , I >  * 1000 :  NEXT 
I 
280  DATA 0 .02 ,0 .1 ,0 .2 ,0 .25 :  REM 
RISK OF GETTING SICK FROM T 
HE GROUP OF HEALTHY 
2 9 0  DATA 0 .05 ,0 .3 ,0 .6 ,0 .75 :  REM 
RISK OF GETTING SICK FROM S 
MOKING 
300  DATA 0 .1 ,0 .2 ,0 .25 ,0 .3 :  REM 
RISK OF GETTING SICK FROM A 
I R-POLLUTI ON 
3 1 0  DATA 0 .39 ,0 ,0 ,0 :  REM RISK 
OF GETTING SICK FROM REPEATE 
D RESPIRATORY INFECTIONS I N  
CHI LDHOOD 
3 2 0  FOR I = 1 TO 4 :  FOR J = 1 TO 
4 :  READ L l ( I , J > :  NEXT J: NEXT 
I 
3 2 9  DATA 0 .88 ,0 .52 ,0 .42 ,0 .14  
330  DATA 0.164,O. 5327,O. 5848,O. 
4938 :  REM PROPORTION OF POP 
ULATION WITH SMOKING 
3 4 0  DATA 0 .31 ,0 .31 ,0 .31 ,0 .32 :  REM 
PROPORTION OF POPULATION UN 
DER A1  R-POLLUTI ON 
3 5 0  DATA 0 .30,0,0,0:  REM PROP0 
RTION OF POPULATION WITH FRE 
QUENT RESPI RATORY DISEGSES I 
N CHILDHOOD 
356 FOR K = 1 TO 4: READ X ( K > :  NEXT 
K 
3 6 0  FOR I = 1 TO 3: FOR J = 1 TO 
4 :  READ N ( I , J >  
3 6 2  N ( 1 , J )  = N ( I , J >  * X ( J >  
3 6 4  ND(T J: NEXT I 
3 7 0  FOR J = 1 TO 4:N2( 1 ,  J) = N (  1 
, J> * P ( l  ,J> :N3(1  ,J> = N ( 2 ,  J 
* P t l , J > : N 4 ( 1 , J >  = N ( 3 , J )  * 
P ( l , J > :  NEXT J: REM ABSOLUT 
EPLE I N  RISK 
3 7 9  DATA 50,30 ,30 ,30  
3 8 0  DATA 0 .69 ,0 .06 ,0 .09 ,0 .04 :  REM 
COEF.OF TRANSITION FROM GRO 
UP WITHOUT SMOKING TO SMOKIN 
G 
390  DATA 0.0005,O .002,0 .002,0  .O 
0 5 5 :  REM COEF.OF TRANSITION 
FROM GROUP WITHOUT RISK TO 
A1  R-POLLUTI ON 
4 0 0  DATA 0 .08 ,0 ,0 ,0 :  REM COEF. 
OF TRANSITION FROM GROUP WIT 
HOUT RISK TO NURSERY 
4 0 5  FOR K = 1 TO 4 :  READ X ( K > :  NEXT 
K 
410 FOR I = 1 T O 3 :  FOR J =  1 TO 
4: READ R l ( 1  ,J) 
412 I F  I = 2 THEN R l ( 1 , J )  = R l ( 1  
, JZ * X ( J )  
413 NEXT J: NEXT I 
500 REM ------ # OF SICK,# OF PE 
OPLE I N  RISK------------- 
510 FOR T = 2 TO 21: REM YEARS 
511 I F  LY = T THEN FOR K1 = 1 TO 
4: FOR K2 = 1 TO 4 : L l ( K l , K 2 )  
= L l ( K l , K 2 )  * LX(K2) / 100: 
NEXT K2: NEXT K1 
514 I F  RY = T THEN FOR K1 = 1 TO 
3 :  FOR K2 = 1 TO 4 :R l (K l ,K2> 
= R l ( K l , K 2 )  * RX(Kl,K2) / 1 
00: NEXT K2: NEXT K1 
520 FOR J = 1 TO 4: REM AGE GRO 
UPS 
530 R = R l ( 1 , J )  + R l ( 2 , J )  + R l ( 3 ,  
J) 
531 P = B: I F  J > 1 THEN P = 0.05 
* N l ( T  - 1 , J  - 1 )  
533 N l ( T , J )  = N l ( T  - 1,J) + P - ( 
R + L l ( 1 , J ) )  * N I ( T  - 1 ,J )  - 
(0 .05  * N1(T - 1 ,J ) )  - (M2(J  
) * N l ( T  - 1 , J ) )  
534 I F  J = 2 THEN N I ( T , J )  = N l ( T  
,J) + 0.05 * N4(T - 1 , J ) :  REM 
RECOVERING FROM RESP.DISEAS 
ES 
536 I F  J = 1 THEN P = 0 
537 I F  J > 1 THEN P = 0.05 * N2( 
T - 1 , J  - 1 )  
538  I F  J =  2 THEN P = P + 0.05 * 
N4<T - l , J  - 1)  
540 N2(T ,J )  = N2(T - 1,J )  + R l ( 1 ,  
J) * N l ( T , J )  + P - ( L l ( 2 , J )  * 
N2(T - 1 , J ) )  - ( 0 . 0 5  * N2(T - 
1 , J ) )  - (M(J>  * N2(T - 1 , J ) )  
542  I F  J > 1 THEN P = 0.05 * N3( 
T - 1 ,J  - 1 )  
550 N3(T,J)  = N3(T - 1 ,J) + R l ( 2 ,  
J) * N l ( T , J )  + P - ( L l ( 3 , J )  * 
N3(T - 1, J ) )  - (0 .05  * N3(T - 
1 , J ) )  - (M(J )  * N3(T - 1 , J ) )  
552 I F  J > 1 THEN N4(T ,J )  = 0: GOTO 
562 
560 N4(T ,J )  = N4(T - 1 ,J )  + R l ( 3 ,  
J) * N I ( T , J )  + P - ( L l ( 4 , J )  * 
N4(T - 1 ,J)) - (0 .05  * N4(T - 
1 , J ) )  - (M(J )  * N4(T - 1 , J ) )  
5 6 2  I F  J > 1 THEN P = 0 . 0 5  * N5( 
T - l , J  - 1 )  
570 N 5 ( T , J )  = N 5 ( T  - 1 ,  J) + L l ( 1 ,  
J) * N l ( T  - 1 , J )  + L l ( 2 , J )  * 
N 2 ( T  - 1 , J )  + L l ( 3 , J )  * N 3 ( T  
- 1 , J )  + L l ( 4 , J )  * N 4 ( T  - 1 
,J) + P - ( N 5 ( T  - 1 , J )  * (M I  
(J)  t M ( J > > >  
400 NEXT J: NEXT T 
410 HOME 
620 PRINT "PRESS";: INVERSE : PRINT 
" G " ; :  NORMAL : PRINT " I F  Y 
OU PREFER RESULTS I N  GRAPHS" 
630 INPUT A%:PP% = MID% (A%, 1 , l  
> : I F  PPQ = " G" THEN GOTO 1 
500  
1000 REM ------- PRINTOUTS------- 
-- 
1001  PR# 1: PRINT 
1010 PRINT TAB( 1 1 ) " I  N P U T 
D A T A " :  PRINT TAB( 1 1 ) ; " F  
OR SLOVAKIA 1783"  : FOR I = 1 
TO 40:  PRINT " " "  ;: NEXT I: PRINT 
: PRINT : PRINT 
1011  PRINT "NOTE" : P R I M  TAB( 6 
> ; "RISK GROUP#l - WITHOUT R I  
SKU:  PRINT TAB( 1 7 > ; " # 2  - S 
MOKERS": PRINT TAB( 1 7 > ; " # 3  
- A I R  - POLLUTION " :  PRINT 
TAB( 1 7 )  ; " # 4  - RESPIRATORY 
INFECT1 ONS" : 
1 0 1 2  PRINT : PRINT : PRINT TAB( 
1 0 ) ; " P  0 P U L A T I 0 N " :  FOR 
I = 1 TO 40 :  PRINT ".";: NEXT 
I:: PRINT : PRINT 
1 0 1 4  PRINT TAB( 6 > ; " 0  - 1 9 " ;  TAB( 
1 7 )  ; " 2 0  - 3 9 "  ; TAB( 29 )  ; " 4 0  
- 5 9 " ;  TAB( 3 9 )  ;" 60 -" 
1 0 1 5  PRINT TAB( 4 > ; P ( l , l > ;  TAB( 
1 5 > ; P ( 1 , 2 > ;  TAB( 2 7 > ; P ( 1 , 3 > :  
TAB( 3 9 > ; P ( 1 , 4 >  
1 0 1 6  PRINT : PRINT : PRINT "NUMB 
ER OF N E W B 0 R N S:" ;B:  PRINT 
: PRINT 
1 0 1 7  PRINT TAB( 1 1 ) ; " M  0 R T A  
L I T Y " :  PRINT TAB( 11) ; "W 
ITHOUT COPD CASES": FOR I = 
1 TO 40:  PRINT ".";: NEXT I: 
PRINT 
1 0 1 8  PRINT TAB( 6 ) ; "O  - 1 9 " ;  TAB( 
1 7 > ; " 2 0  - 3 9 " ;  TAB( 2 9 > ; " 4 0  
- 5 9 " ;  TAB( 3 9 ) ; "  60 -" 
1 0 1 9  PRINT TAB( 4 > ; D S ( ' l > ;  TAB( 
1 5 )  ; D 5 i  2 )  ; TAB( 2 7 )  ; D5( 3 )  ; TAB( 
39 )  ;D5(4> 
1020 PRINT : PRINT : PRINT TAB( 
11);"M 0 R T A L I T Y " :  PRINT 
TAB( 11 ) ; " SPECI F I  C FOR COPD 
" :  FOR I = 1 TO 40: PRINT " .  
" ; :  NEXT I: PRINT 
1021 PRINT TAB( 6) ; "O - 1 9 " ;  TAB( 
17) ; "20 - 3 9 " ;  TAB( 29 ) ; "40  
- 59" ;  TAB( 3 9 ) ; "  60 - "  
1022 PRINT TAB( 4 > ; 0 4 ( 1 > ;  TAB( 
15) ;04(2> ; TAB( 27) ;04(3> ; TAB( 
39>;D4(4>:  PRINT : PRINT 
1023 PRINT TAB( 16) ;"R I S K n :  PRINT 
TAB( 12);"OF GETTING SICK": 
FOR I = 1 TO 40: PRINT " . " ;  
: NEXT I: PRINT : PRINT 
1025 PRINT "RISK";  TAB( 6);"O - 
19" ;  TAB( 17) ; "20 - 39" ;  TAB( 
29) ;"40 - 59"  ; TAB( 39) ;" 
60 -" 
1027 PRINT " # I " ;  TAB( 4>;L1(1 ,1)  
; TAB( 15> ;L1 (1 ,2> ;  TAB( 27) 
;L1(1,3) ; TAB( 39) ;L1(1 ,4> 
1029 PRINT "#2" ;  TAB( 4> ;L1 (2 ,1>  
; TAB( 15) ;L1(2 ,2) ;  TAB( 27) 
;L1(2 ,3>;  TAB( 39>;L1(2 ,4)  
1030 PRINT " # 3 " ;  TAB( 4>;L1(3 ,1> 
; TAB( 15) ;L1(3 ,2>;  TAB( 27) 
;L1(3 ,3>;  TAB( 39) ;L1(3,4) 
1031 PRINT " # 4 " ;  TAB( 4>;L1(4 ,1> 
; TAB( 15) ;L1(4 ,2>;  TAB( 27) 
;L1 (4 ,3 ) ;  TAB( 39>;L1(4 ,4>:  PRINT 
: PRINT 
1035 PRINT TAB( 3 ) ; " P  R 0 P 0 R 
T I 0 N OF POPULATION": PRINT 
TAB( 1 7 ) ; " I N  RISK": FOR I = 
1 TO 40: PRINT " . " ; : NEXT I : 
PRINT : PRINT 
1037 PRINT "RISK";  TAB( 6);"O - 
19" ; TAB( 17) ; " 20 - 39" ; TAB( 
29>; "40 - 5 9 " ;  TAB( 39) ; "60  
, u 
1039 PRINT "#2"  ; TAB( 4) ;N( 1 , l )  ; 
TAB( 15) ;N( 1,2) ; TAB( 27) ;N 
(1 ,3)  ; TAB( 39) ;N( 1,4> 
1040 PRINT " # 3 " ;  TAB( 4) ;N(2 ,1) ;  
TAB( 15) ;N(2 ,2) ;  TAB( 27);N 
( 2 , 3 ) ;  TAB( 39) ;N(2,4> 
1041 PRINT "444"; TAB( 4>;N(3 ,1) ;  
TAB( 15) ;N(3 ,2) ;  TAB( 27);N 
(3 ,3)  ; TAB( 39) ;N(3,4) 
1042 PRINT : PRINT 
1045 PRINT TAB( 6);"COEF.OF T R 
A N  S I T I O N " :  PRINT "FR 
OM GROUP WITHOUT RISK TO ONE 
WITH RISK": FOR I = 1 TO 40 
: PRINT " . "  ; : NEXT I : PRINT 
: PRINT 
1 0 4 7  PRINT " R I S K " ;  TAB( 6 ) ; " 0  - 
1 9 " ;  TAB( 1 7 > ; " 2 0  - 3 9 " ;  TAB( 
29) ; " 4 0  - 5 9 " ;  TAB( 39) ; " 6 0  
- 
1 0 4 8  PRINT "442"; TAB( 4 > ; R X ( l , l >  
; TAB( 1 5 )  ;RX(1 , 2 )  ; TAB( 2 7 )  
;RX(1 ,3> ;  TAB( 3 9 ) ; R X ( 1 , 4 )  
1 0 4 9  PRINT "443"; TAB( 4 ) ; R 1 ( 2 , 1 )  
; TAB( 1 5 > ; R 1 ( 2 , 2 ) ;  TAB( 2 7 )  
; R 1 ( 2 , 3 > ;  TAB( 3 9 > ; R 1 ( 2 , 4 >  
1050 PRINT " # 4 " ;  TAB( 4 > ; R 1 ( 3 , 1 >  
; TAB( 1 5 > ; R 1 ( 3 , 2 > ;  TAB( 2 7 )  
; R 1 ( 3 , 3 > ;  TAB( 3 9 > ; R 1 ( 3 , 4 > :  PRINT 
: PRINT 
1051  PRINT : PRINT : PRINT TAB( 
2 ) ; " C O P D  M O R B I  D I T  
Y " ; :  FDR I = 1 TO 40 :  PRINT 
".";: NEXT I: PRINT 
1 0 5 3  P R I M  TAB( 6 ) ; " O  - 1 9 " ;  TAB( 
1 7 > ; " 2 0  - 3 9 " ;  TAB( 2 9 > ; " 4 0  
- 5 9 " ;  TAB( 3 9 ) ; "  60  -" 
1 0 5 5  PRINT TAB( 4 )  ;N5( 1 , l )  ; TAB( 
1 5 )  ; N 5 ( 1  ,2> ;  TAB( 2 7 )  ;N5(1  , 3  
> ; TAB( 3 9 )  ;N5( 1 , 4 >  
1 0 5 7  FOR I = 1 TO 4 0 :  PRINT " * "  ; 
: NEXT I: PRINT : PRINT : PRINT 
1060  I F  SC9 < > " Y n  THEN 1110 
1 0 6 2  PRINT TAB( 5 ) " s  C E N  A R 
I 0  T E S T E D : "  
1 0 6 4  PRINT TAB( 3 )  ;"CHANGE I N  T 
REATMENT EFFECTIVENESS: " 
1 0 6 6  PRINT TAB( 6 )  ; " 0  - 1 9 " ;  TAB( 
1 7 ) ; " 2 0  - 3 9 " ;  TAB( 2 9 ) ; " 4 0  
- 5 9 "  ; TAB( 3 9 )  ;" 60 -" 
1 0 6 5  PRINT TAB( 4 > ; M X ( 1 > ;  TAB( 
1 5 )  ;MX( 2) ; TAB( 27) ;MX( 3 )  ; TAB( 
3 9 )  ;MX( 4 )  
1 0 6 9  PRINT "YEAR OF CHANGE:";MY: 
PRINT : PRINT 
1070  PRINT TAB( 09);"CHANGE I N  
R ISK  FACTORS" 
1 0 7 2  PRINT " R I S K "  ; TAB( 6 ) ; " 0  - 
1 9 " ;  TAB( 1 7 > ; " 2 0  - 3 9 " ;  TAB( 
2 9 > ; " 4 0  - 5 9 " ;  TAB( 3 9 > ; " 6 0  
- 11 
1 0 7 5  PRINT " # 3 " ;  TAB( 4>;f?X(2,1) 
; TAB( 1 5 ) ; R X ( 2 , 2 > ;  TAB( 2 7 )  
;RX(2 ,3>  ; TAB( 39) ;RX(2,4> 
1 0 7 6  PRINT " # 4 " ;  TAB( 4);f?X(3,1> 
; TAB( 1 5 > ; R X ( 3 , 2 > ;  TAB( 2 7 )  
;RX(3 ,3> ;  TAB( 3 9 > ; R X ( 3 , 4 > :  
1 0 7 8  PRINT "YEAR OF CHANGE:";RY 
1080  PRINT : PRINT 
1 0 8 2  PRINT TAB( 10);"CHANGE I N  
PREVENT I ON : " 
1054 PRINT TAB( 6 > ; " 0  - 1 9 " ;  TAB( 
1058 PRINT "YEAR OF CHANGE:" ;LY 
1090 PRINT : PRINT : PRINT 
1110 PRINT TAB( 3);"FORECASTS 0 
F PEOPLE UNDER DIFFERENT" 
1112 PRINT TAB( 1 0 ) ; " H  E A  L T 
H R I S K "  
1114 FOR I = 1 TO 40: PRINT " * "  ; 
: NEXT I 
11 1 6  PRINT : PRINT : PRINT 
1117 PRINT TAB( 13);"W I T H 0 
U T " :  PRINT : PRINT 
1118 PRINT "YE";  TAB( 15);"AGE G 
ROUPS" 
1120 PRINT "AR";  TAB( 6) ; "O - 19 
" ;  TAB( 17 ) ; "20  - 3 9 " ;  TAB( 
29> ; "40 -59 " ;  TAB( 3 9 ) ; "  60 
- 11 
1122 FOR I = 1 TO 49: PRINT " . " ;  
: NEXT I: PRINT 
1200 FOR T = 1 TO 21 
1210 PRINT T - 1 ; TAB( 4) ; ~ l  (T,I 
1 ;  TAB( 1 5 > ; N l ( T , 2 ) ;  TAB( 27 
> ; N l ( T , 3 ) ;  TAB( 3 9 > ; N l ( T , 4 )  
1220 NEXT T 
1222 PRINT : PRINT : PRINT TAB( 
8);"CIGARETTE S M 0 K I N G 
" :  PRINT : PRINT 
1224 PRINT "YEH; TAB( 1S);"AGE G 
ROUPS" 
1226 PRINT "AR";  TAB( 6 > ; " 0  - 19 
"; TAB( 17 ) ; "20  - 39" ;  TAB( 
29 ) ; "40 -59 " ;  TAB( 3 9 ) ; "  60 
," 
1228 FOR I = 1 TO 49: PRINT " . " ;  
: NEXT I: PRINT 
1230 FOR T = 1 TO 21 
1232 PRINT T - 1 ; TAB( 4 )  ;N2(T,1 
1 ;  TAB( 15)  ;N2(T,2);  TAB( 27 
>;N2(T,3) ;  TAB( 39);N2(T,4) 
1234 NEXT T 
1240 PRINT : PRINT : PRINT TAB( 
7 ) ; " A I  R - P O L L U T I  0 
N " :  PRINT : PRINT 
1242 PRINT "YE" ; TAB( 15)  ;"AGE G 
ROUPS" 
1244 PRINT "ARM; TAB( 6);"O - 19 
" ;  TAB( 1 7 ) ; " 2 0  - 3 9 " ;  TAB( 
29> ; "40 -59 " ;  TAB( 39 ) ; "  60 
- 81 
1246 FOR I = 1 TO 49: PRINT " . " ;  
: NEXT I: PRINT 
1248 FOR T = 1 TO 21 
1250 PRINT T - 1 ; TAB( 4 )  ;N3(T,1 
> ;  TAB( 15>;N3(T ,2> ;  TAB( 27 
> ;N3(T ,3 i  ; TAB( 39)  ;N3(T,4> 
1252 NEXT T 
1260 PRINT : PRINT : PRINT TAB( 
5);"FREQ.RESP.I N F E C T I 
0 N Sn:  PRINT : PRINT 
1262 PRINT "YE";  TAB( 15);"AGE G 
ROUPSn 
1264 PRINT "ARM; TAB( 6 > ; " 0  - 19 
" ; TAB( 17) ; "20 - 39"  ; TAB( 
29>; "40-59" ;  TAB( 3 9 ) ; "  60 
, " 
1266 FOR I = 1 TO 49: PRINT "."; 
: NEXT I: PRINT 
1268 FOR T = 1 TO 21 
1270 PRINT T - 1 ; TAB( 4 )  ;N4(T,1 
> ;  TAB( 15) ;N4(T,2>;  TAB( 27 
> ;N4(T, 3 )  ; TAB( 39)  ;N4(T, 4)  
1272 NEXT T 
1280 PRINT : PRINT : PRINT TAB( 
14);"FORECAST OFn: PRINT TAB( 
7 ) ; " C O P D  M O R B I  D I T  
Y" 
1282 FOR I = 1 TO 40: PRINT " ^ "  i 
: NEXT I: PRINT : PRINT 
1284 PRINT "YE" ; TAB( 15) ;"AGE G 
ROUPS" 
1256 PRINT 'AR"; TAB( 6 i ; " O  - 19 
" ; TAB( 17) ; " 20 - 39"  ; TAB( 
29>; "40-59" ;  TAB( 3 9 ) ; "  60 
," 
1288 FOR I = 1 TO 49: PRINT " . " ;  
: NEXT I: PRINT 
1290 FOR T = 1 TO 21 
1292 PRINT T - 1 ; TAB( 4) ;N5(T,1 
1 ;  TAB( 15) ;N5(T,2>;  TAB( 27 
> ;N5(T,3> ; TAB( 39)  ;N5(T,4> 
1274 NEXT T 
1300 PRINT : PRINT : PRINT TAB( 
14);"FORECAST OF": PRINT TAB( 
5 ) ; " P O P U L A T  I O N  I N  
S S R "  
1302  FOR I = 1 TO 40: PRINT " ^ "  i 
: NEXT I: PRINT : PRINT 
1304 PRINT "YE" ; TAB( 15)  ;"AGE G 
ROUPS" 
1306 PRINT "AR";  TAB( 6 )  ; " 0  - 19 
" ;  TAB( 17) ; " 20  - 3 9 " ;  TAB( 
29) ; "40-59" ;  TAB( 39)  ;" 60 
- u 
1308 FOR I = 1 TO 49: PRINT " . " ;  
: NEXT I: PRINT 
1310 FOR T = 1 1 0  21 
1312 PRINT T - 1;  TAB( 4) ;P(T,1> 
; TAB( 1 5 > ; P ( T , 2 > ;  TAB( 2 7 ) ;  
P(T,3> ; TAB( 39) ;P(T,4> 
1314 NEXT T 
1400 REM FOR1 = 1 TO 4: PRINT N1 
(20  ,I> + N2(20,1 
> + N3(20,1>  + N 
4 ( 2 0 , I >  + N5(20 ,1> :  NEXT I 
1499 GOT0 2000 
1500 REM 
1505 MX = 0:MN = 200000000 
1510 FOR T = 1 TO 21: FOR J = 1 TO 
4:P(T,J> = INT (P (T ,J>  / 10 
o o o o >  
1515 I F  P (T ,J>  > MX THEN MX = P( 
T , J >  
1520 I F  P(T, J> < MN THEN MN = P( 
T , J >  
1525 NEXT J: NEXT T 
1530 D = 75 / MX 
1539 MX = 0:MN = 2000000 
1540 FOR T = 1 TO 21: FOR J = 1 TO 
4:N2(T,J> = INT (N2(T, J> / 
10000> 
1541 I F  N2(T,  J> > MX THEN MX = N 
2(T ,  J> 
1542 I F  N2(T,  J> < MN THEN MN = N 
2(T ,J>  
1545 NEXT J: NEXT T 
1546 D l  = 75 / MX 
1549 MX = 0 
1550 FOR T = 1 TO 21: FOR J = 1 TO 
4:N5(T,J) = INT (N5(T,J)  / 
100000) 
1551 I F  N5(T, J) > MX THEN MX = N S(T,J> 
1555 NEXT J: NEXT T 
1556 D2 = 75 MX 
1600 HGR : HCOLOR= 3: ROT= 0 : SCALE= 
1 
1610 HPLOT 0,O TO 0,75 TO 130,75 
TO 130,O TO 0,O 
1620 HPLOT 149,O TO 149,75 TO 27 
9,75 TO 279,O TO 149,O 
1630 HPLOT 0 ,84  TO 0,159 TO 130, 
159 TO 130,84 TO 0,84 
1700 ZN8 = "POPULATION FORECASTn: 
X = 15:Y = 7:  GOSUB 1800 
1710 ZN8 = "SM0KERS":X = 174:Y = 
7: GOSUB 1800 
1720 Z N I  = "COPD CASES" : X  = 15:Y = 
91 : GOSUB 1800 
1790 GOT0 1900 
1800 FOR I 1  = 1 TO LEN ( Z N I > : I I  
= ASC ( M I D I  ( Z N B , I l , l > >  - 
31: I F  I 1  < 1 THEN I 1  = 1 
1 8 1 0  DRAW I 1  AT X + 6 * I 1 , Y :  NEXT 
I 1  : RETURN 
1 9 0 0  FOR T = 1 TO 2 1 :  FOR J = 1 TO 
4 
1 9 0 5  I F  J = 1 THEN HCOLOR= 2 
1 9 0 6  I F  J = 2 THEN HCOLOR= 3 
1 9 0 7  I F  J = 3 THEN HCOLOR= 5 
1 9 0 8  I F  J = 4 THEN HCOLOR= 6 
1 9 1 0  X I  = ( T  - 1 )  * 6:X2 = T * 6 :  
Y1 = 7 5  - ( P ( T  - 1 , J )  * D) :Y  
2 = 75 - ( P ( T , J >  * D >  
1 9 5 0  HPLOT X I  ,Y1 TO X2 ,Y2  
1 9 6 0  X I  = 1 4 9  + ( T  - 1 )  * 6:X2 = 
T * 6 + 1 4 9 : Y l  = 75 - ( N 2 ( T  - 
1 , J )  * D 1 > : Y 2  = 75 - ( N 2 ( T , J  
) * D l )  
1 9 6 3  HPLOT X 1 , Y l  TO X2,Y2 
1 9 7 0  X I  = ( T  - 1 )  * 6 : X 2 = T  * 6 :  
Y1  = 1 5 9  - ( N 5 ( T  - 1 ,J> * D2 
> :Y2 = 1 5 9  - ( N 5 ( T ,  J) * D2) 
1 9 7 5  HPLOT X 1 , Y l  TO X2,Y2 
1 9 8 0  NEXT J: NEXT T 
2 0 0 0  PR# 0 
2 0 0 1  GOTO 1 0 0 0 0  
4 0 0 0  REM PREPAI R SCEIVARI OS 
4 0 0 1  HOME : PRINT : PRINT : PRINT 
: PRINT 
4 0 1 0  PRINT "FOLLOWING SCENARIOS 
ARE TO TEST: " 
4 0 1  1 PRINT TAB( 1 5 )  ;"CHANGE I N  
TREATMENT EFFECTIVENESSu 
4 0 1 2  PRINT TAB( 15);"CHANGE I N  
R I  SK FACTORS" 
4 0 1 3  PRINT TAB( 1 5 )  ;"CHANGE I N  
PREVENT1 ON" 
4 0 3 0  PRINT "ENTER % OF CHANGE OF 
TREATMENT : " 
4 0 3 1  PRINT " 0-19 : "  ; : INPUT A%: I F  
A% = " " THEN 4 0 3 4  
4 0 3 2  MX(1 )  = VAL ( MID% (A%,1 ,3>  
) 
4 0 3 4  PRINT " 2 0 - 3 9 : " ; :  INPUT A%: I F  
A% = " " THEN 4 0 3 8  
4 0 3 6  MX(2 )  = VAL ( MID% (A%,1 , 3 >  
) 
4 0 3 8  PRINT " 4 0 - 6 0 : " ; :  INPUT A%: I F  
A% = " "  THEN 4 0 4 2  
4 0 3 9  MX(3 )  = VAL ( MID% (A%,1 ,3>  
) 
4 0 4 2  PRINT " 6 0 -  :";: INPUT A%: I F  
A% = " "  THEN 4 0 5 0  
4 0 4 3  MX(4 )  = VAL ( MID% (A%,1 ,3>  
4 0 4 5  PRINT "ENTER YEAR OF CHANGE 
( 1 - 2 0 ) " ; :  INPUT MY: I F  MY > 
20 THEN 4 0 4 5  
4 0 4 9  PRINT : PRINT  
4 0 5 0  PRINT "ENTER % OF CHANGE I N  
SMOKING HABITS: "  
4 0 5 1  PRINT " 0 - 1 9 : "  ; : INPUT A%: I F  
A% = " "  THEN 4 0 5 4  
4 0 5 2  R X ( 1 , l )  = VAL ( MID% ( A % , l ,  
3 )  > 
4 0 5 4  PRINT " 2 0 - 3 9 : " ; :  INPUT A%: I F  
AS = " "  THEN 4 0 5 8  
4 0 5 6  R X ( 1 , 2 >  = VAL ( MID% ( A % , l ,  
3 )  > 
4 0 5 8  PRINT " 4 0 - 6 0 : " ; :  INPUT A%: I F  
A% = " " THEN 4 0 6 2  
4 0 5 9  RX(1 ,3>  = VAL ( M I D I  (A%,1,  
3) > 
4 0 6 2  PRINT  " 6 0 -  :"; :  INPUT A s :  I F  
A% = " "  THEN 4 0 7 0  
4 0 6 3  RX(1 ,4>  = VAL ( M I D %  (A%,1,  
3 )  > 
4 0 7 0  PRINT "ENTER % OF CHANGE I N  
AIR-POLLUTION:"  
4 0 7 1  PRINT ' 0 - 1 9 : "  ; : INPUT A%: I F  
A% = " "  THEN 4 0 7 4  
4 0 7 2  R X ( 2 , l )  = VAL ( MID% (A%,1 ,  
3 )  > 
4 0 7 4  PRINT " 2 0 - 3 9 : "  ; : INPUT A%: I F  
A% = " "  THEN 4 0 7 8  
4 0 7 6  RX(2 ,2 )  = VAL ( MID% (A%,1, 
3 )  
4 0 7 8  PRINT " 4 0 - 6 0 : "  ; : INPUT A%: I F  
A% = " "  THEN 4 0 8 2  
4 0 7 9  R X ( 2 , 3 >  = VAL ( MID% (A%,1, 
3 )  > 
4 0 8 2  PRINT " 6 0 -  :"; :  INPUT A%: I F  
A% = "' THEN 4 0 9 0  
4 0 8 3  RX(2 ,4>  = VAL  ( MID% ( A % , l ,  
3) > 
4 0 8 9  PRINT : P R I N T  
4 0 9 0  PRINT  "ENTER % OF CHANGE I N  
FRE0.RESP.DIS. IN CHILDHODD: 
11 
4 0 9 1  PRINT " 0 - 1 9 : " ; :  INPUT A%: I F  
A% = " "  THEN 4 1 0 5  
4 0 9 2  R X ( 3 , 1 >  = VAL  ( MID% (A%,1, 
3) > 
4 1 0 5  PRINT "ENTER YEAR OF CHANGE 
( 1 - 2 0 ) : " ; :  INPUT RY: I F  RY > 
2 0  THEN 4 1 0 5  
4 1 1 0  PRINT "ENTER % OF CHANGE I N  
EFFECTIVENESSu: PRINT ' I N  
PREVENT1 ON" 
4 1 1 1  PRINT " 0-19 : ' ; :  INPUT A%: I F  
A% = " "  THEN 4 1 1 4  
4 1 1 2  L X ( 1 )  = VAL ( MID% (A%,1 ,3>  
) 
4 1 1 4  PRINT " 2 0 - 3 9 : " ; :  INPUT k8: I F  
A 8  = " "  THEN 4 1 1 8  
4 1 1 6  L X ( 2 )  = VAL ( MID% (A%,1 ,3 )  
) 
4 1 1 8  PRINT " 4 0 - 6 0 : " ; :  INPUT AS: I F  
AS = " "  THEN 4 1 2 2  
4 1 1 9  L X ( 3 )  = VAL ( MID% (A%,1,3)  
) 
4 1 2 2  PRINT " 6 0 -  :";: INPUT A%: I F  
A 3  = " "  THEN 4130  
4 1 2 3  L X ( 4 )  = VAL ( M I D 3  ( A 3 , 1 , 3 )  
) 
4 1  2 5  PRINT "ENTER YEAR OF CHANGE 
( 1 - 2 0 ) " ; :  INPUT LY :  I F  LY  > 
20 THEN 4 1  2 5  
4 1  3 0  REM 
5 0 0 0  RETURN 
1 0 0 0 0  END 
